Adam K. Simpson, Chief Executive Officer at Icosavax, Inc. (ICVX), sold 23,576 shares at $8.86 ($209K) on 2023-07-31, disclosed to the SEC on 2023-08-01.
Scheduled sale ($209k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.86 | 11,788 | $104K | 50.0% |
| 2 | $8.86 | 11,788 | $104K | 50.0% |
| Total | $8.86 avg | 23,576 | $209K | 100% |
| Filing → |
| ICVX | SELL | 2023-12-22 | $3.3M | — | Filing → |
| ICVX | SELL | 2023-02-15 | $160K | — | Filing → |
| ICVX | SELL | 2022-12-23 | $1.2M | — | Filing → |